184 related articles for article (PubMed ID: 22086979)
1. Paraoxonase 1 as a major bioactivating hydrolase for olmesartan medoxomil in human blood circulation: molecular identification and contribution to plasma metabolism.
Ishizuka T; Fujimori I; Nishida A; Sakurai H; Yoshigae Y; Nakahara K; Kurihara A; Ikeda T; Izumi T
Drug Metab Dispos; 2012 Feb; 40(2):374-80. PubMed ID: 22086979
[TBL] [Abstract][Full Text] [Related]
2. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.
Ishizuka T; Yoshigae Y; Murayama N; Izumi T
Drug Metab Dispos; 2013 Nov; 41(11):1888-95. PubMed ID: 23946449
[TBL] [Abstract][Full Text] [Related]
3. Human carboxymethylenebutenolidase as a bioactivating hydrolase of olmesartan medoxomil in liver and intestine.
Ishizuka T; Fujimori I; Kato M; Noji-Sakikawa C; Saito M; Yoshigae Y; Kubota K; Kurihara A; Izumi T; Ikeda T; Okazaki O
J Biol Chem; 2010 Apr; 285(16):11892-902. PubMed ID: 20177059
[TBL] [Abstract][Full Text] [Related]
4. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
[TBL] [Abstract][Full Text] [Related]
5. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
6. Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration.
Bełtowski J; Wójcicka G; Marciniak A
Acta Biochim Pol; 2002; 49(4):927-36. PubMed ID: 12545199
[TBL] [Abstract][Full Text] [Related]
7. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.
Khersonsky O; Tawfik DS
Biochemistry; 2005 Apr; 44(16):6371-82. PubMed ID: 15835926
[TBL] [Abstract][Full Text] [Related]
8. Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284.
Tavori H; Aviram M; Khatib S; Musa R; Mannheim D; Karmeli R; Vaya J
Free Radic Biol Med; 2011 Jan; 50(1):148-56. PubMed ID: 21044882
[TBL] [Abstract][Full Text] [Related]
9. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
10. 5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential substrate for paraoxonase 1.
Eryanni-Levin S; Khatib S; Levy-Rosenzvig R; Tamir S; Szuchman-Sapir A
Biochim Biophys Acta; 2015 Sep; 1851(9):1118-22. PubMed ID: 25958017
[TBL] [Abstract][Full Text] [Related]
11. Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL.
Cohen E; Aviram M; Khatib S; Artoul F; Rabin A; Mannheim D; Karmeli R; Salamon T; Vaya J
Free Radic Biol Med; 2014 Nov; 76():14-24. PubMed ID: 25091896
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent.
Tougou K; Nakamura A; Watanabe S; Okuyama Y; Morino A
Drug Metab Dispos; 1998 Apr; 26(4):355-9. PubMed ID: 9531524
[TBL] [Abstract][Full Text] [Related]
13. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition effect of some dihydroxy coumarin compounds on purified human serum paraoxonase 1 (PON1).
Erzengin M; Basaran I; Cakir U; Aybey A; Sinan S
Appl Biochem Biotechnol; 2012 Nov; 168(6):1540-8. PubMed ID: 22971832
[TBL] [Abstract][Full Text] [Related]
15. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
[TBL] [Abstract][Full Text] [Related]
16. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
17. Integrative analytical approach by capillary electrophoresis and kinetics under high pressure optimized for deciphering intrinsic and extrinsic cofactors that modulate activity and stability of human paraoxonase (PON1).
Renault F; Carus T; Cléry-Barraud C; Elias M; Chabrière E; Masson P; Rochu D
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1346-55. PubMed ID: 19945920
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase 1 and homocysteine metabolism.
Perła-Kaján J; Jakubowski H
Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
[TBL] [Abstract][Full Text] [Related]
19. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
20. HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress.
Deakin SP; Bioletto S; Bochaton-Piallat ML; James RW
Free Radic Biol Med; 2011 Jan; 50(1):102-9. PubMed ID: 20850524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
